ID: ALA5270947

Max Phase: Preclinical

Molecular Formula: C16H14O5

Molecular Weight: 286.28

Associated Items:

Representations

Canonical SMILES:  COc1cccc2oc3cc(C)c(O)c(CO)c3c(=O)c12

Standard InChI:  InChI=1S/C16H14O5/c1-8-6-12-13(9(7-17)15(8)18)16(19)14-10(20-2)4-3-5-11(14)21-12/h3-6,17-18H,7H2,1-2H3

Standard InChI Key:  YRDJXNRZNOUOGI-UHFFFAOYSA-N

Associated Targets(non-human)

Influenza A virus 11224 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 286.28Molecular Weight (Monoisotopic): 286.0841AlogP: 2.46#Rotatable Bonds: 2
Polar Surface Area: 79.90Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.89CX Basic pKa: CX LogP: 2.24CX LogD: 2.24
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.71Np Likeness Score: 1.22

References

1. Takahashi JA, Barbosa BVR, Lima MTNS, Cardoso PG, Contigli C, Pimenta LPS..  (2021)  Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic.,  46  [PMID:34438338] [10.1016/j.bmc.2021.116366]

Source